Advanced Prostate Cancer

Home » Advanced Prostate Cancer

Video: “Androgen Deprivation Therapy 2.0”

Videos, Awareness Nights, Advanced Prostate Cancer, Hormone Side Effects, Hormone Therapy / By / / 1 minute of reading

Jan. 2025 Awareness Night Dr. Urban Emmenegger MD Medical Oncologist, Odette Cancer Centre (Division of Medical Oncology) Associate Scientist, Sunnybrook Research Institute (Biological Sciences Platform) Associate Member, Institute of Medical Science, University of Toronto     CLICK ON THE ARROW TO START THE VIDEO The Complete Presentation time is 1:47:47 Disclaimer:  The contents of this video is solely for the purposes of education and information and does not constitute personal diagnostic advice or personal medical advice.   

Video: “Androgen Deprivation Therapy 2.0” Read More »

Video: “The Evolution of Treatment Intensification in Advanced Prostate Cancer”

Videos, Awareness Nights, Advanced Prostate Cancer / By / / 1 minute of reading

November 2022 Awareness Night Dr. Olivier Heimrath, MD FRCSC Staff Urologist, Humber River Hospital Associate Urologist, Michael Garron Hospital Lecturer, University of Toronto   CLICK ON THE ARROW TO START THE VIDEO The Complete Presentation time is 1:31:31 Disclaimer:  The contents of this video is solely for the purposes of education and information and does not constitute personal diagnostic advice or personal medical advice.   

Video: “The Evolution of Treatment Intensification in Advanced Prostate Cancer” Read More »

Video: “Management of Advanced Prostate Cancer”

Videos, Awareness Nights, Advanced Prostate Cancer / By / / 1 minute of reading

July 2022 Awareness Night Dr. Di (Maria) Jiang, MD, Msc, FRCPC Staff Oncologist, Genitourinary Group Princess Margaret Cancer Centre, UHN Asst Prof., Clinician Investigator, Dept of Medicine, U. of Toronto   CLICK ON THE ARROW TO START THE VIDEO The Complete Presentation time is 1:33:48 Disclaimer:  The contents of this video is solely for the purposes of education and information and does not constitute personal diagnostic advice or personal medical advice.   

Video: “Management of Advanced Prostate Cancer” Read More »

Video: “Advanced Prostate Cancer”

Videos, Awareness Nights, Advanced Prostate Cancer / By / / 1 minute of reading

January 2021 Awareness Night Treatment of Advanced Prostate Cancer: From A(palutamide) to Z(ytiga(tm))  Dr. Urban Emmenegger, MD Medical Oncologist, Odette Cancer Centre (Div. of Medical Oncology) and Sunnybrook Research Institute (Biological Sciences Platform) Assistant Professor, Dept. of Medicine, U. of Toronto Associate Member, Inst. of Medical Science, U. of Toronto CLICK ON THE ARROW TO START THE VIDEO The Complete Presentation time is 2:15:05 <

Video: “Advanced Prostate Cancer” Read More »

A Phase III clinical trial of high-intensity exercise in the management of advanced prostate cancer

Advanced Prostate Cancer, Exercise / By / / 1 minute of reading

According to a news release just issued by Queen’s University, Belfast, a group of  150 researchers around the world is coming together to expand enrollment and access to the Australian INTERVAL trial into a global trial to test whether serious exercise should be prescribed as part of the treatment for men with advanced prostate cancer. Read the article.

A Phase III clinical trial of high-intensity exercise in the management of advanced prostate cancer Read More »

Adding chemotherapy to hormone therapy added 14 months to patients’ lives in study

Advanced Prostate Cancer, Chemotherapy, Hormone Therapy / By / / 1 minute of reading

Chemotherapy at the start of hormone therapy can extend the lives of men with prostate cancer that has spread beyond the gland, a new study finds. Over nearly 29 months of follow-up, men with advanced prostate cancer who received the combination therapy lived almost 14 months longer than men who received only hormone therapy (58 months versus 44 months), researchers said. Read the article.

Adding chemotherapy to hormone therapy added 14 months to patients’ lives in study Read More »

Increased Risk of Diabetes among Patients Receiving Primary Androgen Deprivation Therapy for Clinically Localized Prostate Cancer.

Advanced Prostate Cancer, Hormone Therapy / By / / 1 minute of reading

Androgen deprivation therapy (ADT) may increase diabetes risk. As benefits of primary ADT (PADT) for localized PCa are controversial, and most PCa survivors are of advanced age with comorbidities, it is important to determine if PADT increases diabetes risk and what are the susceptibility factors. Read the article.  (Free UroToday login required.)

Increased Risk of Diabetes among Patients Receiving Primary Androgen Deprivation Therapy for Clinically Localized Prostate Cancer. Read More »

Scroll to Top